Axiata Among First Three Telcos Globally to Achieve TM Forum’s ‘Running on ODA’ Status
KUALA LUMPUR, Oct 14, 2022 – (ACN Newswire) – Axiata Group Berhad, one of Asia’s…
KUALA LUMPUR, Oct 14, 2022 – (ACN Newswire) – Axiata Group Berhad, one of Asia’s…
HONG KONG, Oct 14, 2022 – (ACN Newswire) – Invest Hong Kong of the Hong…
HONG KONG, Oct 14, 2022 – (ACN Newswire) – Invest Hong Kong will launch a…
HONG KONG, Oct 14, 2022 – (ACN Newswire) – The Hong Kong Trade Development Council…
PORTLAND, Ore.–(BUSINESS WIRE)–Northwest Natural Holding Company (NYSE: NWN) (NW Natural Holdings) announced today it will…
HOUSTON–(BUSINESS WIRE)–Microvast Holdings, Inc. (NASDAQ: MVST), a technology innovator that designs, develops and manufactures lithium-ion…
LONDON and RALEIGH, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
DUBAI, United Arab Emirates, Oct. 14, 2022 (GLOBE NEWSWIRE) — Jax.Network, a blockchain project building…
Internet City, Dubai–(Newsfile Corp. – October 14, 2022) – LBank Exchange, a global digital asset…
BANGKOK, Oct 14, 2022 – (ACN Newswire) – InfoComm Southeast Asia which debuted in 2019…
PETALING JAYA, Malaysia, Oct 14, 2022 – (ACN Newswire) – Samaiden Group Berhad (Bursa: SAMAIDEN,…
Avery Restaurant Consulting recently entered Travel & Hospitality Tech Outlook’s 2022 list of Top 10…
WHITE PLAINS, N.Y.–(BUSINESS WIRE)–FRMO Corp. (the “Company” or “FRMO”) (OTC Pink: FRMO) today reported its…
JAKARTA, Oct 14, 2022 – (ACN Newswire) – Indonesia’s Ministry of Agrarian Affairs and Spatial…
BEIJING & BURLINGTON, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a leading global biopharmaceutical company, with a…
Notice of Patent Allowance in Australia containing broad claims pertaining to treating ADD/ADHD using the…
Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing Enliven’s portfolio of precision oncology…
Company presenting technologies for improving patient outcomes in wound care WINNIPEG, Manitoba, Oct. 13, 2022…
Dosing in KT-474 Phase 1 HS and AD patient cohort (Part C) complete KT-413 and…
REDWOOD CITY, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) — Seer, Inc. (NASDAQ: SEER), a life…